Literature DB >> 11757829

Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis.

D J Kim1, J H Do, W Huh, Y G Kim, H Y Oh.   

Abstract

OBJECTIVE: To evaluate the peritoneal clearance of middle molecules in comparison with the peritoneal clearance of small molecules in incremental peritoneal dialysis (PD). STUDY
DESIGN: Peritoneal clearances of creatinine and beta2-microgloblulin (B2M) were compared in 57 continuous ambulatory PD patients on full dose of 4 exchanges, and 54 incremental PD patients with 2 or 3 exchanges over 24 hours. Clearances were also compared when there were changes in the PD regimen, such as in the number of exchanges and the duration of the dwell time.
SETTING: Tertiary-care university hospital.
RESULTS: Peritoneal creatinine clearance increased almost linearly with the increase in the number of exchanges. In contrast, peritoneal clearance of B2M was 9.1 +/- 3.6 L/week, 8.8 +/- 4.4 L/week, and 7.9 +/- 2.5 L/week with 2,3, and 4 exchanges, respectively, per day, amounts that were not different from each other. Peritoneal clearance of B2M did not change when there was an increase in the number of dialysate exchanges from 2 to 3 and from 3 to 4 over a period of 24 hours; whereas the peritoneal clearance of creatinine increased. Peritoneal clearance of B2M almost doubled, from 5.4 +/- 2.7 L/week with 2 exchanges over 12 hours per day, to 9.5 +/- 4.4 L/week with the same 2 exchanges over 24 hours. The creatinine clearance did not change.
CONCLUSION: In contrast to peritoneal clearance of small molecules, such as creatinine, which was dependent on the number of dialysate exchanges, peritoneal clearance of middle molecules, such as B2M, depended mainly on the total dwell hours of PD and not on the number of exchanges of peritoneal dialysate in incremental PD. This might be another advantage of incremental PD, since peritoneal clearance of middle molecules in incremental PD over 24 hours can be comparable to that in full dose PD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757829

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  9 in total

1.  Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014.

Authors:  Loris Neri; Giusto Viglino; Giancarlo Marinangeli; Anna Rachele Rocca; Alessandro Laudon; Antonino Ragusa; Gianfranca Cabiddu
Journal:  J Nephrol       Date:  2017-05-12       Impact factor: 3.902

2.  Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

Authors:  Sunil V Badve; Deborah L Zimmerman; Greg A Knoll; Kevin D Burns; Brendan B McCormick
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

3.  Influence of Different Payment Schemes on the Clinical Outcome in Peritoneal Dialysis Patients.

Authors:  Chun-yan Su; Xin-hong Lu; Tao Wang
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

4.  The choice of peritoneal dialysis catheter implantation technique by nephrologists.

Authors:  T Yip; S L Lui; W K Lo
Journal:  Int J Nephrol       Date:  2013-01-28

5.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388

6.  Associations between small and middle molecules clearance and the change of cognitive function in peritoneal dialysis.

Authors:  Yi Li; Hai-Chen Pi; Zhi-Kai Yang; Jie Dong
Journal:  J Nephrol       Date:  2019-10-23       Impact factor: 3.902

7.  Beta-trace protein as a potential biomarker of residual renal function in patients undergoing peritoneal dialysis.

Authors:  Philipp Lutz; Rainer Peter Woitas; Sebastian Schwab; Carola Ellen Kleine; Dominik Bös; Sylvie Bohmann; Christian P Strassburg
Journal:  BMC Nephrol       Date:  2021-03-11       Impact factor: 2.388

8.  Serum β2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients.

Authors:  David A Jaques; Andrew Davenport
Journal:  J Nephrol       Date:  2020-12-03       Impact factor: 3.902

Review 9.  The Peritoneal Membrane-A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis.

Authors:  Margarita Kunin; Pazit Beckerman
Journal:  Membranes (Basel)       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.